Fluorine-Thiol Displacement Stapling on the Disordered αB of pKID Domain Increases Its Helicity and Affinity to KIX
The development of high-affinity ligands specifically targeting intrinsically disordered protein interactions has remained challenging due to the lack of well-defined binding pockets and shallow binding surfaces commonly found at their interfaces. Here, we employed our fluorine-thiol displacement reaction (FTDR) peptide-stapling platform to synthesize a library of peptide-based ligands derived from the α<sub>B</sub>-helix of the disordered pKID to target its binding partner KIX. Our library revealed that helical formation and affinity to KIX is highly favored when the α<sub>B</sub> peptide was stapled at sites corresponding to Arg<sup>135</sup> and Ser<sup>142</sup>, further supporting the hypothesis that stabilization of α<sub>B</sub> significantly influences the overall binding affinity of pKID to KIX. We also found that the highest binding peptide, α<sub>B</sub>-RSpS, may form secondary contacts at the MLL site on KIX in addition to binding at the primary pKID site. Lastly, no binding to KIX was observed for any α<sub>B</sub>-stapled peptide that lacked the conserved helix-flanking prolines Pro<sup>132</sup> and Pro<sup>146</sup>. Conserved helix-flanking prolines have previously been shown to modulate the binding affinities of other disordered domains in other proteins including MLL and p53. However, to our knowledge this is the first evidence within α<sub>B</sub> of pKID.
Authors
- Andrew J. Andrews (ORCID: https://orcid.org/0000-0002-2529-3714)
- Carson Cohen (ORCID: https://orcid.org/0000-0002-4348-8283)
- Rongsheng E. Wang (ORCID: https://orcid.org/0000-0002-5749-7447)
Institutions
- University of North Carolina Wilmington (US)
- Temple University (US)
Publication Details
- Journal
- Synlett
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1055/a-2409-3840
- Primary Topic
- Blood disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Research Corporation for Science Advancement
- Temple University
- National Institutes of Health